Orphan designation: deucrictibant monohydrate Treatment of bradykinin-mediated angioedema, 25/03/2025 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 4 April 2025 - 11:18

Orphan designation: deucrictibant monohydrate Treatment of bradykinin-mediated angioedema, 25/03/2025 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-25-3040

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters